Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
BOXR-1030 by SOTIO Biotech for Squamous Cell Carcinoma: Likelihood of Approval
BOXR-1030 is under clinical development by SOTIO Biotech and currently in Phase II for Squamous Cell Carcinoma. According to GlobalData,...